All posts tagged Theravance

biopharma

UK pharmaceuticals group GSK considers taking full control of US partner Theravance

UK pharmaceuticals maker GlaxoSmithKline Plc (LON:GSK) may take full control of its US partner Theravance Inc (NASDAQ:THRX) if the latter’s respiratory drugs get the green light by the US Food and Drug Administration (FDA), Piper Jaffray (NYSE:PJC) analyst Ian Somaiya …

Continue Reading...

Powered by WordPress